The Royal Marsden Hospital (RMH) and The Institute of Cancer Research (ICR) is the largest and most comprehensive cancer centre in Europe, treating over 50,000 NHS and private patients every year. It is a centre of excellence with an international reputation for ground-breaking research and pioneering the very latest in cancer treatments and technologies, as well as specialising in cancer diagnosis and education. The Royal Marsden, with the ICR, is the only National Institute for Health Research Biomedical Research Centre dedicated solely to cancer. The RMH/ICR has had extensive experience with a wide range of molecular radiotherapy procedures for over 30 years and has published widely. The Radioisotope Physics Group has an international reputation in quantitative imaging with PET and SPECT and has introduced imaging and dosimetry protocols that have become widespread clinical practice. The scientific lead was a founder member of the EANM Dosimetry Committee and has run and been closely involved with a number of European projects within Framework 7 and the COST scheme.
For more information go to www.icr.ac.uk and www.royalmarsden.nhs.uk.
Imperial College London regularly scores within the top 5 universities in the world. It is a thriving international community combining excellence in research and innovation with a vibrant entrepreneurial culture.
The National Heart & Lung Institute (NHLI) is one of the major departments undertaking heart and lung research worldwide. The NHLI continues to retain its position as a highly respected research centre carrying out research, development and education in cardiovascular and respiratory science. This is achieved through a powerful blend of top-notch academics, excellent facilities, effective teaching and productive collaborations. The NHLI was the highest ranked of Imperial’s medical departments in the last survey of research quality (REF 2014).
For more information go to www.imperial.ac.uk.
Newcastle University was formed, as a medical school, in 1834, and is a member of the prestigious Russell Group of 24 public research universities in the UK. Part of the Faculty of Medical Sciences, the Institute of Health and Society (IHS) was formed in 2006, focussing on research on applied epidemiology, decision-making and organisation of care, life-course, development and ageing, and public health involvement. The IHS has been at the forefront of radiation epidemiology studies in the UK, publishing the first direct epidemiological evaluation of the cancer risks following CT scans of children and adolescents in 2012.
For more information go to www.ncl.ac.uk.